quofenix
a. menarini industrie farmaceutiche riunite s.r.l. - delafloxacin meglumină - infecții dobândite în comunitate - antibacteriene pentru uz sistemic, - quofenix is indicated for the treatment of the following infections in adults:acute bacterial skin and skin structure infections (absssi),community-acquired pneumonia (cap), when it is considered inappropriate to use other antibacterial agents that are commonly recommended for the initial treatment of these infections (see sections 4. 4 și 5. trebuie luate în considerare ghidurile oficiale referitoare la utilizarea adecvată a medicamentelor antibacteriene.
levofloxacin kabi 5 mg/ml
fresenius kabi polska sp. z o.o - polonia - levofloxacinum - sol. perf. - 5mg/ml - chinolone antibacteriene fluorochinolone
levofloxacina sandoz 5 mg/ml
lek pharmaceuticals d.d. - slovenia - levofloxacinum - sol. perf. - 5mg/ml - chinolone antibacteriene fluorochinolone
levofloxacina aurobindo 5 mg/ml
apl swift services (malta) limited - malta - levofloxacinum - sol. perf. - 5mg/ml - chinolone antibacteriene fluorochinolone
levofloxacina actavis 5 mg/ml
balkanpharma-razgrad ad - bulgaria - levofloxacinum - pic. oft.-sol. - 5mg/ml - antiinfectioase antiinfectioase
levofloxacina infomed 5 mg/ml
infomed fluids s.r.l. - romania - levofloxacinum - sol. perf. - 5mg/ml - chinolone antibacteriene fluorochinolone
levofloxacina actavis 5 mg/ml
pharmathen s.a. - grecia - levofloxacinum - sol. perf. - 5mg/ml - chinolone antibacteriene fluorochinolone
levofloxacina actavis 5 mg/ml
pharmathen s.a. - grecia - levofloxacinum - sol. perf. - 5mg/ml - chinolone antibacteriene fluorochinolone
levofloxacina aurobindo 5 mg/ml
apl swift services (malta) limited - malta - levofloxacinum - sol. perf. - 5mg/ml - chinolone antibacteriene fluorochinolone
levofloxacina vioser 5 mg/ml
vioser s.a. parenteral solutions industry - grecia - levofloxacinum - sol. perf. - 5mg/ml - chinolone antibacteriene fluorochinolone